Institution
The George Institute for Global Health
Also known as: George Institute for Global Health · The George Institute
- 8running trials
- 2closed trials
- 12,739publications (OpenAlex)
Running trials
Recruiting
Not yet recruiting
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Recruiting
Recruiting
Recruiting
Recruiting
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Active, not recruiting
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke5 recruiting
- High blood pressure2 recruiting
- Type 2 diabetes2 recruiting
Closed trials
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The George Institute for Global Health
Sydney, New South Wales 2050
8 trials
Division of Critical Care, The George Institute for Global Health
Newtown, New South Wales 2042
1 trial
The George Institute
Sydney, New South Wales 2031
1 trial
NCT04389827Global Kidney Patient Trials Network
The George Institute for Global Health
Brisbane, Queensland 4000
1 trial
NCT05345327SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Contact: Emma Zhang
Conditions
Diseases this institution publishes on or runs trials for.
- Stroke158 works · 5 trials
- Type 2 diabetes76 works · 1 trial
- Chronic kidney disease75 works · 1 trial
- IgA nephropathy11 works · 1 trial
Institution data: ROR 023331s46 (CC0-1.0)Updated 15 Nov 2026